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Abstract
Background: Poisson model has been widely applied to estimate the disease burden of influenza, but there has been little
success in providing reliable estimates for other respiratory viruses.
Methods: We compared the estimates of excess hospitalization rates derived from the Poisson models with different
combinations of inference methods and virus proxies respectively, with the aim to determine the optimal modeling
approach. These models were validated by comparing the estimates of excess hospitalization attributable to respiratory
viruses with the observed rates of laboratory confirmed paediatric hospitalization for acute respiratory infections obtained
from a population based study.
Results: The Bayesian inference method generally outperformed the classical likelihood estimation, particularly for RSV and
parainfluenza, in terms of providing estimates closer to the observed hospitalization rates. Compared to the other proxy
variables, age-specific positive counts provided better estimates for influenza, RSV and parainfluenza, regardless of
inference methods. The Bayesian inference combined with age-specific positive counts also provided valid and reliable
estimates for excess hospitalization associated with multiple respiratory viruses in both the 2009 H1N1 pandemic and
interpandemic period.
Conclusions: Poisson models using the Bayesian inference method and virus proxies of age-specific positive counts should
be considered in disease burden studies on multiple respiratory viruses.
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Introduction
Acute respiratory infections accounted for 11–22% of global
deaths of children under five, with a significant proportion caused
by respiratory viruses [1]. However, obtaining reliable population
based estimates for disease burden of respiratory viruses remains a
challenge. These viruses usually cause overlapping clinical
syndromes, making it difficult to assign viral aetiology based on
the clinical presentations of patients [2]. Moreover, laboratory
tests necessary for case confirmation are not always conducted in
clinical settings owing to limited laboratory capacity [3]. Previous
studies have used several statistical methods to quantify the
morbidity and mortality burden associated with influenza and
respiratory syncytial viruses (RSV) [4]. These methods first
established a baseline level with the assumption of no virus
circulation, and then defined the excess hospitalization or
mortality as the difference between the observed and baseline.
However, few of these methods were able to separately determine
the burden attributable to different respiratory viruses and even
fewer studies have assessed the burden of respiratory viruses other
than influenza and RSV. One commonly used method, Poisson
regression modeling, allows simultaneous assessment of co-
circulating viruses and has become increasingly popular recently.
But our previous study showed that the point estimates derived by
the classical maximum likelihood method for respiratory viruses
other than influenza were unrealistically small and even negative
[5]. The challenge lies in resolving the overlapping peaks of these
co-circulating viruses, and also in adjusting for the confounding
effects of other seasonal factors such as temperature or humidity
[6]. An alternative estimation method, Bayesian inference, could
be used as it has the advantage of incorporating the prior
knowledge on parameter distributions [7]. Another unsolved
problem in disease burden studies is the choice of virus proxy
variables. The numbers or proportions of specimens positive for
different viruses in all specimens tested have been widely used in
previous studies [8,9]. Other less frequently used proxies include
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influenza-like illness rates multiplied by laboratory-test positive
proportions (ILI6LAB) [10]. Although virus attack rates could be
different across age groups due to the heterogeneity in prior
immunity and exposure risks [11–13], no studies have hitherto
integrated age-specific virus data into the models, largely due to
the lack of such data in most regions. In this study we evaluated
the performance of various combinations of model assumption,
virus proxy variables and inference methods, in estimating excess
hospitalization attributable to several co-circulating respiratory
viruses. The estimates have been validated by comparison with
observed rates of laboratory confirmed paediatric hospitalization
rates for acute respiratory infections obtained from a population
based study.
Methods
Data source
Hospital admission records of the two major public hospitals on
the Hong Kong Island (Queen Mary Hospital (QMH) and Pamela
Youde Nethersole Eastern Hospital (PYNEH) were obtained from
the Hong Kong Hospital Authority during the study period of
October 2003–September 2010. We compiled weekly numbers of
hospital admissions with any listed discharge diagnosis of acute
respiratory diseases (ARD) for the age groups of,1, 1–5 and 6–17
years, according to the International Classification of Diseases (9th
Revision, ICD9) codes 460–466 or 480–487. Age specific virology
data were obtained from the Microbiology Laboratory of QMH,
which provides virology diagnostic services for both QMH and
PYNEH, for influenza A (seasonal subtypes H3N2, sH1N1 and
pandemic strain pH1N1), influenza B, respiratory syncytial virus
(RSV), adenovirus and parainfluenza virus types 1–3. This
laboratory tested a total of 80 611 specimens collected from both
QMH and PYNEH during the study period, by using direct
immunofluorescence tests (IF) and viral culture. Reverse tran-
scription polymerase chain reaction (RT-PCR) was only routinely
carried out during the 2009 pandemic [14]. Meteorological data
were obtained from the Hong Kong Observatory.
Poisson model
Poisson models were first fitted to the age-stratified weekly
admission numbers of acute respiratory diseases. A typical form of
this model is
E½logYt~
b0zb1fluAtzb2fluBtzb3RSVtzb5adenotzb4paraflutzs(t)zs(Tempt)
zs(Humdt)
b1, b2, b3,b4,b5*Uniform½0,h ðModel 1Þ
where Yt denotes the numbers of age-specific hospital admissions
at week t (t = 1,2,…,366), and follows a Poisson distribution with
mean mt and variance Qmt. Here Q is an over-dispersion factor to
adjust for the unequal mean and variance [15]. fluAt, fluBt, RSVt,
adenot and paraflut denote the age-specific weekly counts of
specimens positive for influenza A and B, RSV, adenovirus or
parainfluenza viruses, respectively. s(t), s(Tempt) and s(Humdt)
are the natural spline functions of time, weekly average
temperature and relative humidity, respectively. Five degrees of
freedom per year were used for the seasonal trend and two degrees
of freedom for temperature and relative humidity. We used a
Bayesian inference process based on Gibbs sampling (BUGS) [16]
to estimate the parameters. A variety of Bayesian approaches have
been widely applied to calculate the genetic distance in phyloge-
netic analysis [17] and to describe the transmission dynamics of
influenza viruses [18]. By incorporating prior knowledge on the
distribution of parameter with available data, the Bayesian
inference method could provide a posterior distribution closer to
the true underlying distribution [19]. Due to the known adverse
effects of the viruses on hospital admissions, we assumed that the
parameter of virus proxy variable followed a non-negative
distribution. Therefore the coefficients of these variables b1, b2,
b3, b4 and b5 were estimated by a Bayesian process, under the
distribution assumption of Uniform[0,h]. The posterior distribution
of each covariate parameter was estimated by repeating a Monte
Carlo Markov Chain simulation for 50,000 iterations with 25,000
burn-in iterations. Based on our previous findings [20], the starting
point of h was set to 10, to cover the range of excess risk from 0–
20% associated with 10% increase in virus proxies.
In addition to age-specific positive counts, we tried different
combinations of virus proxies with the Bayesian inference method
on virus coefficients: age-specific proportions of positive specimens
(Model 2), all-ages proportions (Model 3) or all-ages influenza-like
illness rates multiplied by all-ages proportions (ILI6LAB, model
4). Besides the commonly adopted log linear Poisson regression
models that assumed multiplicative effects of viruses, we also tried
linear Gaussian models that assumed additive effects of influenza
(Model 5) [10,21]. To compare the Bayesian approach with our
previous models based on classical likelihood estimation, we fitted
the classical log linear Poisson models with the proxies of age-
specific counts (Model 6), age-specific proportions (Model 7) and
all-ages proportions (Model 8).
Model validation
Baseline hospitalization for influenza A subtype H3N2 was first
calculated from the model as the expected weekly numbers of
admissions when the H3N2 proxy variable was set to zero and all
the other variables were kept as the observed values. Excess
hospitalization attributable to H3N2 was defined as the sum of
difference between the observed and baseline hospitalization [22].
Similar calculation was repeated for other subtypes of influenza A,
influenza B, RSV, adenovirus and parainfluenza, respectively.
Annual excess rate of hospitalization was separately calculated for
each year, by dividing the annual total number of excess
hospitalization by the mid-year age-specific population in the
Hong Kong Island obtained from the year 2006 census.
Annual excess rates estimated by these statistical methods were
then compared with the directly observed admission rates for a
population based systematic sample of laboratory confirmed cases
of respiratory virus infections, who were admitted into the QMH
and PYNEH with any listed diagnosis of ARD during the same
period. The details of data collection for the directly observed
virologically confirmed hospitalization rates have been described
elsewhere [23]. Briefly, nasopharyngeal aspirates from patients
who were younger than 18 years and admitted with symptoms of
acute respiratory infection on one chosen day (Wednesday or
Thursday) of each week, were all tested for five respiratory viruses
by IF. Since these two hospitals provide acute paediatric hospital
services for approximately 70% of the population in Hong Kong
Island, we could estimate the population based age-specific
hospitalization rates from this cohort. We calculated the mean of
absolute percentage difference between the annual age-specific
estimates and corresponding virologically confirmed observed
hospitalization rates, and chose the most optimal model as that
with the smallest mean difference. We also assessed the lag effects
of these viruses by replacing the virus proxy variables with the
proxies at the weeks up to three weeks before the current (lag1, 2
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and 3), to take into account of the potential delay between the
virus infection and hospital admissions. For simplicity, the same
lag was used for all the virus proxies in the model. In order to
assess whether our method could differentiate the impacts of
viruses during the interpandemic and pandemic periods, we
calculated the excess rates separately for the 2009 H1N1 influenza
pandemic period of May 2009 to August 2010, and for the
preceding interpandemic period of October 2003 to April 2009.
All the analysis was performed by the statistical packages R
(version 2.5.1) and WinBUGS (version 1.4.3).
Ethical approval was obtained from the Institutional Review
Board of the University of Hong Kong/Hospital Authority Hong
Kong West Cluster (UW 11-264). Informed consent was not
obtained because patient records were anonymized and de-
identified prior to analysis.
Results
The mean absolute percentage difference between the annual
age-specific rates of excess hospitalization derived from different
models and the corresponding observed rates is shown in Table 1.
In the models using the same virus proxies, the estimates from the
models using the Bayesian inference showed smaller deviations
from the observed rates than the classical likelihood estimates,
particularly for RSV, parainfluenza and adenovirus. In the models
using the Bayesian inference, compared to the other virus proxies,
age-specific counts provided the estimates with smaller deviation
from the true observed rates for most viruses (Table 1). The log-
link models (Model 1) offered the estimates closer to the observed
rates than the identity-link models (Model 5), with the exception of
parainfluenza. Overall, the log-link Poisson models using the
Bayesian inference and the proxies of age-specific counts (Model 1)
provided the most reliable estimates for the excess hospitalization
associated with influenza A and B, RSV, parainfluenza and
adenoviruses. Therefore we chose this model as the final one and
presented the estimates from this model in the rest part of this
paper. The lag effects up to three weeks were separately assessed
by replacing the age-specific positive counts virus at the current
week (lag 0) with those at one to three weeks before (lag 1–3).
These models with different lag week consistently provided the
estimates more deviant from the observed rates, compared to the
proxy variables at the current week (Table 2).
Annual excess rates of hospitalization were slightly lower than
the directly observed rates for influenza A subtypes sH1N1, H3N2,
pH1N1 and influenza B in all the age groups, without any pattern
of consistent under- or over-estimation observed in any of these
age groups (Figure 1). For RSV, excess rates tended to be higher
than the observed hospitalization rates, particularly for the ,1 age
groups. Most of the estimates for parainfluenza were smaller than
the observed rates. The greatest deviation from the observed rates
was found in adenovirus.
Compared to the interpandemic period, the 2009 H1N1
pandemic was associated with an obvious increase in the observed
rates of laboratory confirmed cases for RSV, but a decrease in
other viruses (Table 3). Overall the model provided the estimates
similar to the directly observed rates of all the viruses under study
Table 2. Mean absolute percentage difference of excess
hospitalization rates from annual hospitalization rates of
laboratory confirmed infections in a pediatric cohort.
Lag weeks Lag 1 Lag 2 Lag 3
Influenza A
sH1N1 52.5 70.9 81.5
H3N2 44.5 62.5 70.0
pH1N1 57.8 68.5 78.5
Influenza B 41.7 62.7 72.5
RSV 62.2 102.6 77.6
Parainfluenza 65.2 94.9 86.4
Adenovirus 65.4 71.6 62.8
Excess rates were estimated from the log-linear Poisson model using a Bayesian
approach with the virus proxies of age-specific positive counts at the different
lag weeks.
doi:10.1371/journal.pone.0090126.t002
Figure 1. Comparison of annual excess hospitalization rates
per 10,000 population and directly observed rates during each
of the seven seasons, for (A) sH1N1, (B) H3N2, (C) pH1N1, (D)
influenza B, (E) respiratory syncytial virus (RSV), (F) parainflu-
enza and (G) adenovirus. Excess hospitalization rates were derived
from the WinBUGS models with age-specific counts as virus proxy.
doi:10.1371/journal.pone.0090126.g001
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during the pandemic period, except slight overestimation in H3N2
and influenza B, and underestimation in adenovirus. The model
performance was comparable between the interpandemic and
pandemic periods for all the viruses.
Discussion
Time series models have widely adopted by recent studies to
estimate the disease burden of influenza and RSV [24,25]. In this
study we compared the Bayesian inference method with the
classical likelihood estimation, in terms of obtaining more reliable
estimates for the disease burden of co-circulating viruses including
influenza, RSV, parainfluenza and adenovirus. Under the
assumption of positive association between respiratory virus
activity and hospitalization, the Bayesian inference method
successfully separated the individual effects of multiple respiratory
viruses, which the previous models have not or only partially
achieved [5,26]. With the exception of adenovirus, the model
estimates closely matched the true hospitalization rates across
different age groups that were observed in a pediatric cohort under
a systematic surveillance for respiratory virus infections. We
speculated that underestimation in adenovirus was probably due
to its less clear seasonal pattern and relatively lower positive
isolation rate compared to the other viruses (Figure 2). Neverthe-
less, the models overall offered the satisfactory estimates which
were within the close range of true hospitalization rates without
exaggeration.
Taking the advantage of long standing virology data with linked
age information in Hong Kong, this study for the first time added
the age-specific virology data as proxy in the time series models for
disease burden studies. We found that age-specific counts showed
the best performance among all the proxies when combined with
either the Bayesian or classical likelihood inference methods. In
previous studies, we used all-ages proportion as proxy because it
took into account the temporal variations in total numbers of
specimens collected. However, this might not be the case for age-
specific virology data, as relatively small numbers of total
Table 3. Comparison of weekly directly observed rates (per 100,000 population) and excess rates of hospitalization associated
with influenza estimated by the Bayesian approach, during the interpandemic period (4 January 2004–25 April 2009) and
pandemic period (26 April 2009–14 August 2010).
Virus/Age group Interpandmic Pandemic
Directly observed
rates Excess rates (95% CI)
Directly observed
rates Excess rates (95% CI)
sH1N1
,1 4.2 3.2 (0.3, 6.6) 0.0 0.4 (0.0, 1.0)
1–5 3.9 2.9 (1.0, 4.6) 0.7 0.8 (0.3, 1.3)
6–17 0.6 0.6 (0.3, 0.9) 0.1 0.1 (0.0, 0.1)
H3N2
,1 8.9 12.0 (6.9, 17.3) 5.7 8.1 (4.6, 11.6)
1–5 6.2 9.0 (7.0, 11.0) 5.1 6.4 (4.9, 8.0)
6–17 0.7 0.9 (0.6, 1.2) 0.3 0.9 (0.6, 1.3)
pH1N1
,1 na na 17.2 11.3 (1.2, 21.9)
1–5 na na 12.4 12.2 (8.2, 16.3)
6–17 na na 2.9 2.6 (2.0, 3.2)
Influenza B
,1 2.8 1.9 (0.1, 5.1) 0.0 0.8 (0.0, 2.2)
1–5 5.6 5.9 (4.0, 8.0) 0.7 5.2 (3.4, 7.0)
6–17 1.0 1.1 (0.8, 1.4) 1.0 1.1 (0.8, 1.6)
RSV
,1 36.5 48.1 (38.7, 57.0) 45.8 48.3 (39.3, 57.9)
1–5 10.6 9.0 (5.1, 12.6) 12.7 12.4 (7.0, 17.2)
6–17 0.1 0.3 (0.0, 0.7) 0.2 0.4 (0.0, 1.1)
Parainfluenza
,1 24.8 15.9 (8.0, 23.7) 13.3 11.6 (5.7, 17.6)
1–5 9.9 5.0 (1.8, 8.0) 10.9 6.3 (2.2, 10.3)
6–17 0.1 0.2 (0.1, 0.4) 0.3 0.4 (0.1, 0.8)
Adenovirus
,1 10.3 2.4 (0.1, 5.4) 5.7 2.2 (0.1, 5.1)
1–5 9.6 1.7 (0.1, 4.3) 5.5 1.0 (0.0, 2.6)
6–17 0.6 0.5 (0.2, 0.9) 0.1 0.2 (0.1, 0.3)
Abbreviations: RSV, respiratory syncytial virus; NA, not available.
doi:10.1371/journal.pone.0090126.t003
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specimens tested in some age groups could have introduced
spurious peaks in age-specific proportions. We also evaluated the
performance of ILI6LAB proxy, which was found more closely
correlated with the true incidence of influenza during the
interpandemic or pandemic period [21,27]. We found this proxy
provides the estimates closer to the observed rates than age-specific
and all-ages proportions, but slightly worse than the proxy of age-
specific counts in most viruses (Table 1 and Figure 3). Taken
Figure 2. Weekly numbers of specimens positive for influenza A or B, RSV, parainfluenza and adenovirus in the age groups of ,1,
1–5 and 6–17 years.
doi:10.1371/journal.pone.0090126.g002
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together, age-specific counts shall be recommended as proxy
variables if such data are available. If age information is
unavailable, ILI6LAB is probably the proxy that shall be
considered.
The 2009 H1N1 pandemic was characterized with dramat-
ically increased attack rates among children and young adults,
but the severity of pandemic infections was comparable to the
seasonal virus strains [28,29]. ARD admission rates in our
pediatric cohort increased by a proportion ranging from 7% to
170% during the pandemic (Table 1), and many other studies
also reported a similar magnitude of increase [30–33].
However, the admissions due to non-influenza infections
decreased in the pandemic, except RSV. Our model estimates
were able to capture this trend, showing the same change
directions as the observed rates. However, large deviations
were also observed in some age-virus categories, such as
influenza B in the ,1 and 1–5 age groups. Further studies are
warranted to fine tune our modeling approach in order to
derive reliable estimates for different periods.
It has been widely accepted that Poisson distribution is
appropriate to fit the low-frequency count data, but the log-link
function commonly adopted in Poisson models has been criticized
for its assumption of exponential increase in health outcomes
along with one unit increase in virus proxies [8,34]. Some of recent
studies switched to a more ‘‘reasonable’’ assumption of linear
relation by adopting an identity-link function in Poisson models
[35,36]. In this study we found that the log-link function
yielded the estimates slightly closer to the true incidence of
influenza hospitalizations than the identity-link. However, the key
assumption on the association of virus proxies and health
outcomes in Poisson models still remain to be proved. Further
evidence on the mechanism of influenza transmission and
pathogenicity in human community could probably help resolve
this problem.
Our study has potential limitations. First, the Bayesian
estimates are sensitive to the prior distributions and the prior
assumption of nonnegative coefficient for virus proxy variables
needs to be carefully justified. Since our virology data were
obtained from the laboratory surveillance based on hospitalized
inpatients, it is reasonable to assume that these virology data were
positively associated with the increase of hospital admissions with
viral respiratory infections. However, overestimation might exist
if the assumption of prior distribution is not well justified, and
caution needs to be taken when extending this approach to
estimate the excess mortality of other respiratory viruses, as most
viruses other than influenza cause only mild symptoms that might
not necessarily lead to death [37]. Second, age-specific virus data
requires long standing and intensive virology surveillance for
multiple respiratory viruses, but such surveillance networks may
not be available for influenza in many countries. Nevertheless,
the importance of simultaneous assessment on other respiratory
viruses, particularly RSV, has started to be recognized [26,38].
So we can expect these data will become available in more and
more countries in the near future. Third, we only estimated the
excess hospitalization of five respiratory viruses due to limited
virology data. There are many other respiratory viruses (e.g.
rhinovirus) and bacteria (e.g. Streptococcus pneumonia) also contrib-
ute greatly to ARD hospitalization in children, although the
clinical significance of detection of some of these (e.g. rhinovirus)
remains unclear. Further studies are needed to assess whether
addition of more virology data could alter the performance of
models.
In conclusion, age-specific counts of positive specimens are
probably the best proxies for virus activity and should be used in
the disease burden models if such data are available. In the
absence of age-specific data, the Bayesian inference proposed in
this study is superior to the classical likelihood inference method,
as the former provides more reliable estimates on excess
hospitalization respectively associated with multiple respiratory
viruses.
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